Methods and compositions for the assessment of drug response

a drug response and composition technology, applied in the field of drugs' responses, can solve the problems of not being able to translate into a pharmacodynamic effect, certain drugs to come off the market, and substantial delays
US20110045481A1Inactive Publication Date: 2011-02-24THERANOSTICS LAB

Patent Information

Authority / Receiving Office
US Β· United States
Patent Type
Applications(United States)
Current Assignee / Owner
THERANOSTICS LAB
Publication Date
2011-02-24
Estimated Expiration
Not applicable Β· inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided.
Need to check novelty before this filing date? Find Prior Art

Description

FIELD

[0001] Fields of the invention include responses to pharmaceutical drugs, methods for assessment of drug responses and prediction of subject responses to particular drugs and drug treatment regimes, and analyses of genetic polymorphisms and altered gene expression.BACKGROUND OF THE INVENTION

[0002] The following includes information that may be useful in understanding the present to inventions. It is not an admission that any of the information provided herein is prior art, or relevant, to the presently described or claimed inventions, or that any publication or document that is specifically or implicitly referenced is prior art.

[0003] One recent technological focus in the field of human genomics is pharmacogenomics, which includes efforts to use human DNA, sequence variability in the development and prescription of drugs. Pharmacogenomics is based on the correlation or association between a given genotype and a resulting phenotype. Since the first correlation study over half-a-cen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More